Morning SPAC News Roundup: January 29, 2024
by Nicholas Alan Clayton on 2024-01-29 at 10:31am

At the SPAC of Dawn

SPAC activity is picking back up this week in between the dust settling on the SEC’s new SPAC rule and the Fed breaking its silence on potential rate cuts Wednesday.

As three SPACs look to secure extension votes today, Northview (NASDAQ:NVAC) is among those those hoping to be nearing close. It filed its sixth amended proxy for its combination with medtech firm Profusa on January 16 and released a new investor presentation for the deal this morning.

This provides some key updates from the parties’ initial materials as redemptions at extension votes have reduced Northview’s trust by -95.6%, while the two sides initially anticipated a maximum of 80% redemptions by close. It now has $9.3 million in trust and expects final redemptions to leave it with about $5 million.

It expects to add a further $1 million via a PIPE and to gain $4.4 million more in equity financing from the establishment of a 60/40 joint venture with a Singapore-based entity to license and market its products in the APAC region.

Profusa plans to use about $5 million to $6 million from these final proceeds to fund working capital needs with about $3 million going towards commercializing its glucose monitoring products and $1 million to get its oxygen monitor through its FDA pivotal study.


News and Rumors

  • PR: Science 37 (NASDAQ:SNCE), which combined with LifeSci II in October 2021, has agreed to be acquired by private telehealth firm eMed for $5.75 per share. This is a 21.3% premium over the company’s last closing price. But, Science 37 did a 1-for-20 stock split in December and has shrunk to a market cap of about $28.3 million having struck its SPAC deal at $1.05 billion.
  • Reuters: Electric car maker Polestar Automotive Holding (NASDAQ:PSNY), which combined with Gores Guggenheim, plans to cut around 450 jobs globally, or about 15% of its workforce, amid “challenging market conditions.”
  • TechCrunch: EV de-SPACs Canoo (NASDAQ:GOEV) and Faraday Future (NASDAQ:FFIE) are also rumored to have reduced salaries and furloughed employees. Canoo combined with Hennessy IV in 2020 and Faraday Future with Property Solutions in 2021.

Scheduling Notes

  • Sizzle Acquisition Corp. (Nasdaq: SZZL) has postponed its completion vote, scheduled for January 31, to 9 am ET, on Tuesday, February 6. The SPAC stated that it postponed the meeting because EUR and Sizzle are evaluating potential investments from certain strategic parties in connection with the closing of the combination.

 

Recent Posts
by Nicholas Alan Clayton on 2024-04-18 at 11:50am

AGBA (NASDAQ:AGBA) stock is up over +90% this morning following a +211% premarket spike on news it has signed a definitive agreement to combine with social streaming video platform Triller. AGBA, the company itself, was formed by the $555 million combination between a SPAC of the same name and TAG Companies, a financial services firm...

by Nicholas Alan Clayton on 2024-04-18 at 7:57am

At the SPAC of Dawn Since closing its combination with DHC last month, AI customer engagement firm BEN (NASDAQ:BNAI) has rolled out new partnerships with call center and healthcare clients. And, while it faces a fair bit of competition in the chatbot realm, several high-profile institutions have demonstrated that creating one that provides useful services...

by Nicholas Alan Clayton on 2024-04-17 at 3:05pm

Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...

by Nicholas Alan Clayton on 2024-04-17 at 8:13am

At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...

by Nicholas Alan Clayton on 2024-04-16 at 11:33am

Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved